21st Nov 2022 17:02
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Appoints medical device distributor, Distrauma Medical SL, to distribute its Steriwave nasal photodisinfection in Spain. Distrauma, a national medical device supplier focusing on surgical equipment for hospitals, is headquartered in Barcelona, Spain. "The primary application for Steriwave nasal photodisinfection is nasal decolonization for the prevention of healthcare-associated infections, including surgical site infections," Ondine says.
Current stock price: 24.75 pence
12-month change: down 57%
By Sophie Rose; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Ondine Biomed